Editorial
Policy and governance solutions for ensuring equitable access to cancer medicines in low- and middle-income countries
Abstract
The special article published in the Annals of Oncology by Cherny and colleagues (1) coordinated by the European Society for Medical Oncology (EMSO) International Consortium conducts a comprehensive review and survey-based assessment on accessibility and affordability of cancer drugs globally (1).
